Spots Global Cancer Trial Database for biopsy
Every month we try and update this database with for biopsy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) | NCT05564403 | Recurrent Bilia... Recurrent Dista... Recurrent Gallb... Recurrent Intra... Stage III Dista... Stage III Hilar... Stage III Intra... Stage IV Distal... Stage IV Hilar ... Stage IV Intrah... Unresectable Bi... Unresectable Di... Unresectable Ga... Unresectable In... | Binimetinib Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Echocardiograph... Fluorouracil Leucovorin Calc... Magnetic Resona... Multigated Acqu... Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma | NCT00736450 | Contiguous Stag... Noncontiguous S... Stage I Adult D... Stage III Adult... Stage IV Adult ... | oblimersen sodi... rituximab cyclophosphamid... doxorubicin hyd... vincristine sul... prednisone biopsy microarray anal... immunohistochem... gene expression... cytogenetic ana... | 19 Years - | University of Nebraska | |
| Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate | NCT00459407 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... | defined green t... placebo immunohistochem... immunoenzyme te... laboratory biom... biopsy mass spectromet... high performanc... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer | NCT03816358 | Pancreatic Aden... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | Anetumab Ravtan... Biopsy Biospecimen Col... Gemcitabine Hyd... Ipilimumab Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer | NCT02453620 | Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid... | Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy | NCT01153672 | Male Breast Can... Recurrent Breas... Stage IV Breast... | vorinostat laboratory biom... biopsy F-18 16 alpha-f... positron emissi... anastrozole letrozole exemestane gene expression... | 18 Years - | University of Washington | |
| Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2) | NCT06351371 | Malignant Solid... | Biopsy Biospecimen Col... Computed Tomogr... Erdafitinib Magnetic Resona... | 18 Years - | National Cancer Institute (NCI) | |
| Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer | NCT01116648 | Fallopian Tube ... Ovarian Endomet... Ovarian High Gr... Ovarian Serous ... Ovarian Serous ... Primary Periton... Triple-Negative... | Biopsy Biospecimen Col... Cediranib Malea... Computed Tomogr... Echocardiograph... Magnetic Resona... Multigated Acqu... Olaparib | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies | NCT04068194 | Cholangiocarcin... Gallbladder Car... Stage III Gallb... Stage III Hilar... Stage III Intra... Stage IV Gallbl... Stage IV Hilar ... Stage IV Intrah... | Avelumab Biopsy Biospecimen Col... Computed Tomogr... Hypofractionate... Peposertib | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer | NCT03939897 | Anatomic Stage ... Metastatic Brea... Metastatic HER2... Metastatic Horm... Recurrent Breas... | Abemaciclib Biopsy Biospecimen Col... Copanlisib Hydr... Diagnostic Imag... Echocardiograph... Fulvestrant Multigated Acqu... | 18 Years - | National Cancer Institute (NCI) | |
| Gustave Roussy Cancer Profiling | NCT04932525 | Solid Tumor, Un... | Biopsy | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Histopathological Changes in Mycosis Fungoides | NCT05904522 | Mycosis Fungoid... | biopsy | 18 Years - 100 Years | Bezmialem Vakif University | |
| Accuracy and Safety of Coplanar Template Assistance for Head and Neck Biopsies. | NCT05396183 | Head and Neck N... | 18 Years - 85 Years | Peking University Third Hospital | ||
| Biopsy Study Comparing MRI and Ultrasound Soft Image Fusion Guided Biopsies and Gold Standard Prostate Biopsies. | NCT01455792 | Prostate Cancer | Biopsies using ... Gold standard b... | - | Oslo University Hospital | |
| MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection | NCT03819751 | Prostate Cancer Prostate Neopla... | MRI-targeted pr... | 50 Years - 75 Years | Universitaire Ziekenhuizen KU Leuven | |
| Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer | NCT00546377 | Leukemia Lymphoma | filgrastim pegfilgrastim rituximab sargramostim cyclophosphamid... mitoxantrone hy... pentostatin fluorescence in... gene rearrangem... polymerase chai... protein express... flow cytometry biopsy | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Biomarker Discovery and Validation in Lung Cancer | NCT01147562 | Lung Cancer | Collection of b... | 18 Years - | Public Research Centre Health, Luxembourg | |
| Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis | NCT03317392 | Castration-Resi... Metastatic Pros... Stage IVB Prost... | Biopsy Biospecimen Col... Computed Tomogr... Laboratory Biom... Magnetic Resona... Olaparib Quality-of-Life... Radium Ra 223 D... | 18 Years - | National Cancer Institute (NCI) | |
| Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule | NCT02422433 | Barrett's Esoph... | OFDI Capsule Ma... | 18 Years - | Massachusetts General Hospital | |
| Image-guided Cryoablation of Head, Neck and Spine Tumors | NCT02085941 | Head and Neck N... Malignant Neopl... | Cryoablation Biopsy | 18 Years - | Dana-Farber Cancer Institute | |
| Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00589056 | Lung Cancer | cisplatin etoposide nelfinavir mesy... protein express... immunohistochem... laboratory biom... biopsy radiation thera... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe | NCT05965180 | Prostate Cancer | Fine Needle Pho... | 40 Years - 80 Years | University of Michigan Rogel Cancer Center | |
| Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening | NCT04746872 | Human Papilloma... | Alinity m HR HP... | 25 Years - | Abbott Molecular | |
| Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer | NCT04692675 | Prostate Cancer | mpMRI | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Endodrill vs. Conventional Biopsy. Diagnostics and Genetic Analysis | NCT02601079 | Esophageal Neop... | Endodrill Biops... Conventional Bi... | 18 Years - 85 Years | Region Skane | |
| NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma | NCT05359211 | Recurrent Diffu... Recurrent Diffu... Recurrent Grade... Recurrent Prima... Refractory Diff... Refractory Diff... Refractory Grad... Refractory Prim... Transformed Ind... | Cyclophosphamid... Fludarabine Lisocabtagene M... Polymer-conjuga... X-Ray Imaging Echocardiograph... Multigated Acqu... Bone Marrow Bio... Bone Marrow Asp... Lumbar Puncture Computed Tomogr... Positron Emissi... Biospecimen Col... Biopsy | 18 Years - | Fred Hutchinson Cancer Center | |
| Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations | NCT04548752 | Metastatic Panc... Pancreatic Aden... Stage IV Pancre... | Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Olaparib Pembrolizumab | 18 Years - | National Cancer Institute (NCI) | |
| Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma | NCT05861050 | Blastoid Varian... Mantle Cell Lym... Pleomorphic Var... | Biopsy Biospecimen Col... Bone Marrow Bio... Computed Tomogr... Glofitamab Lenalidomide Obinutuzumab Positron Emissi... Venetoclax | 18 Years - 80 Years | City of Hope Medical Center | |
| Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer | NCT04754425 | Castration-Resi... Castration-Resi... Metastatic Mali... Metastatic Pros... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Biopsy Biospecimen Col... Erdafitinib | 18 Years - | M.D. Anderson Cancer Center | |
| Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC) | NCT02705339 | Carcinoma, Non-... Non-Small Cell ... Nonsmall Cell L... | Rociletinib Biopsy Blood draw | 18 Years - | Washington University School of Medicine | |
| Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors | NCT03878095 | Malignant Solid... Refractory Chol... Refractory Mali... | Biopsy Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Ceralasertib Computed Tomogr... Magnetic Resona... Olaparib | 18 Years - | National Cancer Institute (NCI) | |
| Biomarker Development for Response Prediction by DNA Mutational Analysis | NCT01855061 | Neoplasm Metast... | Biopsy Blood samples Pharmacokinetic... Midazolam clear... | 18 Years - | UMC Utrecht | |
| Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device | NCT02524860 | Prostate Cancer | Focal-Fusion Bx | 18 Years - 80 Years | Focal Healthcare Inc. | |
| Endoscopic Ultrasound Guided Liver Biopsy | NCT03307811 | Hepatic Cancer Hepatic Neoplas... Hepatic Carcino... | 22 gauge needle... | 19 Years - | AdventHealth | |
| A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer | NCT05242965 | Lung Non-Small ... Stage IV Lung C... | CD105/Yb-1/SOX2... Sargramostim Computed Tomogr... Biopsy Biospecimen Col... | 18 Years - | University of Washington | |
| pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer | NCT05799144 | Metastatic Orop... Recurrent Oroph... | DNA Vaccine Human Papilloma... Pembrolizumab Computed Tomogr... Magnetic Resona... Magnetic Resona... Biopsy | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ | NCT04144023 | Breast Ductal C... | Granulocyte-Mac... Multi-epitope H... Therapeutic Con... Echocardiograph... Biospecimen Col... Biopsy | 18 Years - | Mayo Clinic | |
| Study on Fluids Associated to Lung Cancer | NCT02853006 | Lung Cancer | Blood and respi... Biopsy Excised tissues | 18 Years - | University Hospital, Grenoble | |
| Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer | NCT06287775 | Extensive Stage... Stage IV Lung C... | Atezolizumab Biopsy Biospecimen Col... Computed Tomogr... Durvalumab Echocardiograph... Iadademstat Magnetic Resona... Multigated Acqu... | 18 Years - | National Cancer Institute (NCI) | |
| Patient-Derived Organoids for Rectal Cancer | NCT04371198 | Rectum Cancer | Biopsy | 18 Years - | Duke University | |
| CERvical Cancer The InFlammatory Index (CERTIFIKO) | NCT05673252 | Cervical Cancer | Venous blood sa... biopsy | 18 Years - | University of Campania "Luigi Vanvitelli" | |
| Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer | NCT06155305 | Organoids Breast Cancer Neoadjuvant Che... | Biopsy | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer | NCT04628767 | Renal Pelvis an... | Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Doxorubicin Hyd... Durvalumab Gemcitabine Hyd... Magnetic Resona... Methotrexate Pegfilgrastim Therapeutic Con... Vinblastine Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas. | NCT03115138 | Glioblastoma Molecular Disea... | Correlation bet... | 18 Years - | Centre Hospitalier Universitaire, Amiens | |
| Screening for Systemic Amyloidosis Via the Ligamentum Flavum | NCT03923920 | Amyloid Amyloidosis Spinal Stenosis Transthyretin A... Primary Amyloid... | Biopsy | 50 Years - | The Cleveland Clinic | |
| Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions | NCT00391300 | Melanoma (Skin) Non-melanomatou... | bioelectric fie... biopsy histopathologic... | 18 Years - | National Cancer Institute (NCI) | |
| Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma | NCT05836571 | Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Undi... | Biopsy Biospecimen Col... Cabozantinib Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation | NCT05610163 | Locally Advance... Stage II Rectal... Stage III Recta... | Capecitabine 5-fluorouracil Leucovorin calc... Irinotecan Oxaliplatin Long Course Che... Computed Tomogr... Magnetic Resona... Sigmoidoscopy biopsy | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma | NCT05711615 | Metastatic Leio... Metastatic Sarc... Metastatic Soft... Unresectable Le... Unresectable Sa... Unresectable So... | Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Pegylated Lipos... Peposertib | 18 Years - | National Cancer Institute (NCI) | |
| Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer | NCT00052637 | Bladder Cancer | hexaminolevulin... biopsy cystoscopy | 18 Years - | Photocure | |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors | NCT02496208 | Bladder Small C... Bladder Squamou... Bladder Urothel... Clear Cell Rena... Invasive Bladde... Invasive Bladde... Invasive Sarcom... Kidney Medullar... Malignant Genit... Malignant Solid... Penile Carcinom... Penile Squamous... Renal Cell Carc... Renal Pelvis Ur... Sarcomatoid Ren... Stage III Bladd... Stage III Penil... Stage III Renal... Stage III Renal... Stage III Renal... Stage III Urete... Stage III Ureth... Stage IV Bladde... Stage IV Penile... Stage IV Renal ... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr... Ureter Urotheli... Urethral Urothe... | Biopsy Biospecimen Col... Cabozantinib S-... Computed Tomogr... Echocardiograph... Ipilimumab Magnetic Resona... Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer | NCT04809025 | Stomach Neoplas... Endoscopy Biopsy Pathology | endoscopy Surgery | 18 Years - 75 Years | Fudan University | |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines | NCT04535401 | Advanced Colore... Advanced Digest... Advanced Gastri... Advanced Gastro... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Metastatic Colo... Metastatic Dige... Metastatic Gast... Metastatic Gast... Stage III Color... Stage IV Colore... | Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Fluorouracil Irinotecan Hydr... Leucovorin Calc... | 18 Years - | National Cancer Institute (NCI) | |
| Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia | NCT05237960 | Erythroplakia Oral Leukoplaki... | Biopsy Biospecimen Col... Extended Releas... Placebo Adminis... | 21 Years - | University of Arizona | |
| Potential Therapeutic Response In Urogenital Tumors | NCT03551457 | Urogenital Neop... Drug Therapy | Biopsy | 18 Years - | University of Campinas, Brazil | |
| Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluation in Triple Negative Breast Cancer (PEAR-MET) | NCT06182306 | Breast Cancer Triple Negative... | Biopsy | 18 Years - | Ourotech, Inc. | |
| Reflectance Confocal Microscopy in Basal Cell Carcinoma | NCT02623101 | Carcinoma, Basa... | Reflectance con... Punch biopsy Surgical excisi... | 18 Years - | Radboud University Medical Center | |
| TRAIL Study: Feasibility and Pilot | NCT06220656 | Thyroid Nodule Thyroid Neoplas... Thyroid Cancer | Biopsy Active Monitori... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck | NCT05172258 | Head and Neck S... Metastatic Head... Metastatic Hypo... Metastatic Lary... Metastatic Oral... Metastatic Orop... Recurrent Head ... Recurrent Hypop... Recurrent Laryn... Recurrent Oral ... Recurrent Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Lip an... Stage IV Oropha... | Biopsy Biospecimen Col... Computed Tomogr... Ipatasertib Pembrolizumab | 18 Years - | National Cancer Institute (NCI) | |
| Daratumumab in Treating Patients With Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer | NCT03473730 | Bladder Urothel... Clear Cell Rena... Malignant Urina... Metastatic Kidn... Stage IV Renal ... | Biopsy Daratumumab Laboratory Biom... Metastasectomy Nephrectomy | 18 Years - | M.D. Anderson Cancer Center | |
| Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer | NCT02453620 | Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid... | Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer | NCT03233711 | Anal Basaloid S... Anal Canal Cloa... Anal Margin Squ... Stage IIB Anal ... Stage III Anal ... | Biopsy Biospecimen Col... Colonoscopy Computed Tomogr... Digital Rectal ... High Resolution... Magnetic Resona... Nivolumab Patient Observa... Proctoscopy Sigmoidoscopy X-Ray Imaging | 18 Years - | National Cancer Institute (NCI) | |
| MRI and Biomarkers in Prostate Cancer | NCT02241122 | Prostate Cancer | prostate biopsy | 18 Years - 85 Years | Turku University Hospital | |
| Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer | NCT01902173 | Hematopoietic a... Locally Advance... Locally Advance... Metastatic Mali... Metastatic Mela... Stage IIIC Cuta... Stage IV Cutane... Unresectable Ma... Unresectable Me... | Biopsy Biospecimen Col... Computed Tomogr... Dabrafenib Mesy... Magnetic Resona... Trametinib Dime... Uprosertib | 18 Years - | National Cancer Institute (NCI) | |
| Acetic Acid Guided Biopsies Compared With High Definition Endoscopy in the Detection of Barrett's Esophagus | NCT01442506 | Barrett's Esoph... | biopsies biopsy | 18 Years - | Johannes Gutenberg University Mainz | |
| Biomoleculars Markers of Sensitivity to Pre- and Post-operative Chemotherapy of Gastric and Cardia Adenocarcinomas: a Pilot Study | NCT02491840 | Gastric and Car... | Biopsy | 18 Years - | University Hospital, Strasbourg, France | |
| Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer | NCT05672095 | Platinum-Resist... Platinum-Resist... Platinum-Resist... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... | Biopsy Biospecimen Col... Niraparib Questionnaire A... Selenium | 18 Years - | City of Hope Medical Center | |
| Testing ONC201 to Prevent Colorectal Cancer | NCT05630794 | Colorectal Aden... Colorectal Carc... Familial Adenom... Multiple Adenom... | Biopsy Biospecimen Col... Colonoscopy Dordaviprone Questionnaire A... Sigmoidoscopy | 18 Years - | National Cancer Institute (NCI) | |
| Anti-Lag-3 (Relatlinib) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma | NCT06325683 | Recurrent Gliob... | Biopsy Biospecimen Col... Lomustine Magnetic Resona... Nivolumab Relatlimab Surgical Proced... | 18 Years - | National Cancer Institute (NCI) | |
| Biopsy of Calcifications Under Contrast Enhancement Guide (BoCCE) | NCT04862429 | Breast Cancer Calcification | Contrast enhanc... Mammography gui... | 18 Years - | Azienda Unità Sanitaria Locale Reggio Emilia | |
| Gilteritinib for the Treatment of ALK NSCLC | NCT06225427 | Lung Non-Small ... Stage IV Lung C... | Biopsy Biospecimen Col... Computed Tomogr... Echocardiograph... Gilteritinib Magnetic Resona... Questionnaire A... | 18 Years - | University of Michigan Rogel Cancer Center | |
| Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance | NCT04107636 | Breast Cancer | Vacuum assisted... conventional lu... | 18 Years - | Radboud University Medical Center | |
| Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients | NCT05981326 | Breast Cancer | Biopsy Blood samples Questionnaires | 18 Years - | Institut Cancerologie de l'Ouest | |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines | NCT04535401 | Advanced Colore... Advanced Digest... Advanced Gastri... Advanced Gastro... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Metastatic Colo... Metastatic Dige... Metastatic Gast... Metastatic Gast... Stage III Color... Stage IV Colore... | Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Fluorouracil Irinotecan Hydr... Leucovorin Calc... | 18 Years - | National Cancer Institute (NCI) | |
| Choline PET/CT and MRI for Targeted Prostate Biopsy | NCT01751737 | Prostate Cancer | Prostate Cancer... | 40 Years - | University of Michigan | |
| Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery | NCT00513266 | Colorectal Canc... Metastatic Canc... | bevacizumab cetuximab fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin laboratory biom... adjuvant therap... biopsy conventional su... neoadjuvant the... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Effectiveness of the Autologous Blood Patch Method in Lung Biopsies | NCT05904574 | Lung Cancer Pneumothorax | Autologous bloo... Percutaneous tr... | 18 Years - | Trakya University | |
| Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care | NCT01816841 | Lip and Oral Ca... Oral Cavity Ver... Stage 0 Lip and... Tongue Cancer | fluorescence im... biopsy examination Comparison of s... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer | NCT00088829 | Breast Cancer | paclitaxel microarray anal... biopsy neoadjuvant the... Paclitaxel | 18 Years - | Georgetown University | |
| Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes | NCT05687110 | Metastatic Mali... Unresectable Ma... | Biopsy Biospecimen Col... Diagnostic Imag... Novobiocin Sodi... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
